Verastem Oncology
117 Kendrick Street
Suite 500
Needham
MA
02494
United States
Tel: (718) 292-4200
Website: http://www.verastem.com/
Email: info@verastem.com
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a clinical-stage biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. We are driven by the strength, tenacity and courage of those battling cancer – single-minded in our resolve to deliver new therapies that not only keep cancer at bay, but improve the lives of patients diagnosed with cancer. Because for us, it’s personal.
Our team is anchored by core values of character, urgency, respect and excellence. We pride ourselves in being an organization committed to diversity and inclusion in order to achieve and sustain excellence. At Verastem, we believe that empowering employees is what makes them truly care about the important work they do.
Founded: 2010
425 articles about Verastem Oncology
-
Verastem, Inc. To Present New Data At The 12th International Mesothelioma Interest Group Conference
10/8/2014
-
Verastem, Inc. Reports Second Quarter 2014 Financial And Corporate Results
8/8/2014
-
Verastem, Inc. Presents Results And Updated Development Plans At Annual Research And Development Day
7/11/2014
-
Verastem, Inc. To Ring The NASDAQ Stock Market Closing Bell
7/9/2014
-
Verastem, Inc. To Ring The NASDAQ Stock Market Closing Bell And Host Annual Research And Development Day On July 10, 2014
7/8/2014
-
Verastem, Inc. Release: The Potential of Targeting Cancer Stem Cells Through FAK Inhibition In Mesothelioma Reported In American Association for Cancer Research’s Cancer Discovery
6/24/2014
-
Verastem, Inc. Announces Annual Research And Development Day And Webcast
6/18/2014
-
Verastem, Inc. To Present At Upcoming Conferences
6/10/2014
-
Verastem, Inc. Presents Updated Clinical Data From VS-6063 And Paclitaxel Combination Phase 1/1b Study In Patients With Ovarian Cancer At The 2014 American Society of Clinical Oncology Annual Meeting
6/2/2014
-
Boston CEO Conference To Feature Ceos Of Aegerion Pharmaceuticals, Inc., Alkermes plc, Alnylam Pharmaceuticals, Flex Pharma, Genzyme Corporation, Infinity Pharmaceuticals Inc., OvaScience, Sarepta Therapeutics, Tesaro, Inc., Verastem, Inc. And Others June
5/20/2014
-
Verastem, Inc. To Present At Upcoming Investor Conferences
5/14/2014
-
Verastem, Inc. Announces Initiation Of COMMAND Study In Japan
5/12/2014
-
Verastem, Inc. To Present At Upcoming Conferences
4/30/2014
-
Verastem, Inc.'s Louise Phanstiel Named Speaker For Commencement Ceremony
4/29/2014
-
Verastem, Inc. Presents Data On Cancer Stem Cell-Targeting Agents At The 2014 American Association for Cancer Research Annual Meeting
4/10/2014
-
Verastem, Inc. Presents Data On Cancer Stem Cell-Targeting Agents At The 2014 American Association for Cancer Research Annual Meeting
4/9/2014
-
Verastem, Inc. To Present Data On Product Candidates Targeting Cancer Stem Cells At The American Association for Cancer Research Meeting
3/25/2014
-
Verastem, Inc. To Present At The Boston Business Development Conference
3/20/2014
-
Timothy J. Barberich Joins Verastem, Inc. Board Of Directors
3/11/2014
-
Verastem, Inc. Reports Year-End 2013 Financial Results
3/6/2014